key: cord-0893902-3toll7fy
authors: Pandit, Bhaswati; Bhattacharjee, Samsiddhi; Bhattacharjee, Bornali
title: Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India
date: 2021-01-27
journal: Infect Genet Evol
DOI: 10.1016/j.meegid.2021.104734
sha: 623e1aa3c7314d7d709bdb03ab86711316710413
doc_id: 893902
cord_uid: 3toll7fy

Several reports have highlighted the contributions of host factors such as age, gender and co-morbidities such as diabetes, hypertension and coronary heart disease in determining COVID-19 disease severity. However, inspite of initial efforts at understanding the contributions of SARS-CoV-2 variants, most were unable to delineate causality. Hence, in this study we re-visited the contributions of different clades of viruses (G, GR and GH) along with other attributes in explaining the disparity in mortality rates among countries. A total of 26,642 high quality SARS-CoV-2 sequences were included and the A23,403G (S:D614G) variant was found to be in linkage disequilibrium with C14,408 U (RdRp: P323L). Linear regression analyses revealed increase in age [Odds ratio: 1.055 (p-value 0.000358)] and higher frequency of clade-G viruses [Odds ratio: 1.029(p-value 0.000135)] could explain 37.43% of the differences in mortality rates across the 58 countries (Multiple R-squared: 0.3743). Next, Machine-Learning algorithms LogitBoost and AdaboostM1 were applied to determine whether countries belonging to high/low mortality groups could be classified using the same attributes and accurate classification was achieved in 70.69% and 62.07% of the countries, respectively. Further, evolutionary analyses of the Indian viral population (n = 662) were carried out. Allele frequency spectrum, nucleotide diversity (π) values and negative Tajima's D values across ORFs were indicative of population expansion. Network analysis revealed the presence of two major clusters of viral haplotypes, namely, clade-G and a variant of clade L [L(v)] having the RdRp:A97V amino acid change. Clade-G genomes were found to be evolving more rapidly and were also found in higher proportions in three states with highest mortality rates namely, Gujarat, Madhya Pradesh and West Bengal. Thus, the findings of this study and results from in vitro studies highlighting the role of these variants in increasing transmissibility and altering response to antivirals reflect the role of viral factors in disease prognosis.

Coronavirus disease 2019 outbreak was first reported in December, 2019 from Wuhan, China and since then has spread across the globe causing ˃5,00,000 deaths worldwide WHO, 2020) . The causal agent, SARS-CoV-2 is a positive strand RNA virus speculated to be of animal origin which has been found to cluster among 6 major clades circulating across countries. The first viral whole genome (RNA) sequence information was published on 5 th of January, 2020 and so far >2,68,000 SARS-CoV-2 sequences have been submitted from across the world to Global Initiative on Sharing All Influenza Data (GISAID) (GISAID, 2020). However, a report from Shanghai, China describing viral variants from patients visiting a clinic between January and February 2020 were unable to find any association between viral haplotypes and enhanced viral dissemination or disease severity.

However, clinical data from these patients were instrumental in identifying host predictive factors such as reduced CD4+ and CD8+ T cell counts with elevated IL-6 and IL-8 levels . Further, age, gender and comorbidities such as hypertension, diabetes and coronary heart disease have also been implicated in disease severity. The daily cumulative indices which are indicative of rapid increase in infected individual numbers have also been found to result in higher deaths in different countries due to health-care resource constraints (Al-Tawfiq et al., Hence, in this report we revisit the role of viral genome variations found across the globe and explore if viral haplotype changes in combination with known host factors such as age could be used to explain the variability that we see in mortality rates given the incidence rates across the globe. Further, we also make an effort at elucidating the evolutionary trajectories of the Indian viral population and its distribution profiles to see if the world-wide patterns are being replicated in India as well.

Age and SARS-CoV-2 clade information were obtained from the GSAID database on the 11 th of June 2020. Countries that did not have age information or did not have more than three complete, high coverage sequence submissions were excluded from the analyses. Information on cumulative COVID-19 incidence and deaths were collected from the WHO database on the same day. The ratio of cumulative death given the cumulative incidence was used as a variable to determine mortality rates.

A total of 26642 high quality SARS-CoV-2 sequences belonging to 59 countries were downloaded on the 11 th of June 2020 from the GSAID database (Supplementary table S1 ). This included countries from Asia (n=19), Africa (n=5), Europe (n=26), North America (n=3), South America (n=5) and Oceania (n=1).

Additionally, viral genome sequences from Indian nationals and a few international tourists stranded in the country, both submitted from India were also included (n=662). From a total of 662 sequences, 25 were found without state information out of which 14 were Indian citizens from Iran and 5 were Italian tourists. Additionally, 7 had been grown in Vero cells. The Pradesh (n=5) and West Bengal (n=47). State-wise average ages were calculated for those states that had contributed more than three viral sequences to the GISAID database.

Given the initial emergence of the SARS-CoV-2 virus from Wuhan, China, alignment was carried out using the genome sequence submitted by Wu et. al. (NC_045512.2) in January 2020 . Reference guided sequence alignment was executed with five iterations for both.

Since different sequencing platforms had been used to generate SARS-CoV-2 sequence data with different error rates and filtering cut-offs so variant calling was stringently carried out with a minimum coverage of one-third genomes. Ambiguous bases found in genome sequences were considered to be unresolved for the purpose of analyses.

Watterson's estimator (θ w ), nucleotide diversity (π) and Tajima's D (Tajima, 1989) for each open reading frame (ORF) was calculated using MEGA X (Kumar, 2018) .

Phylogenetic analysis was carried out following the median-joining approach using Network 10.1.0.0 software (Bandelt H-J, 1999) . For phylogeny construction, a variant frequency cutoff of ≥ 0.01 was used and a 97% cutoff for the number of sequences with resolved bases for each position to avoid spurious clustering.

Measures of linkage disequilibrium (LD) such as D' and r 2 values (Jennings, 1917) were calculated manually using observed and expected frequencies of haplotypes formed by the loci of interest. Linear regression was carried out to assess the importance of variables such as Age 

Mortality rate was defined as the ratio of cumulative deaths and cumulative incidence as on 25.06.2020.

Machine-Learning was used to assess whether countries belonging to high/low mortality groups could be classified based on the percentage of different clades of viruses and other attributes. For this, the Waikato Environment for Knowledge Analysis (Weka 3.8.4) (Frank et al., 2016) software suite was used. Countries with death rates above the median value of 2.8% were labeled as high death rate countries. Two major boosting algorithms AdaboostM1 (Friedman et al., 2000) and LogitBoost (Freund & Schapire, 1996) were used in conjunction with simple decision stumps (as weak learners) and 10 iterations to predict high/low mortality groups. The mortality rate classification was based on the median COVID-19 death rate (section 2.6). The predictor variables used were Age (average age of reported cases), Income (World Bank income group classification), Tests (tests per million as on June 25, 2020), and percentage of different clades of viruses. The accuracy of the models was further tested using 10-fold cross-validation.

The sequences from all the 59 countries excluding India which had patient information on age and more than 3 sequence submissions were analyzed to delineate the frequency of nonsynonymous changes that had been used to classify the virus into clades (Supplementary table S1-1). Comparisons were made to delineate the role all the predictors. Linear regression analysis revealed that increase in age [Odds ratio: 1.055 (p-value= 0.000358)] and the higher frequency of the G-clade viruses [Odds ratio:1.029 (p-value 0.000135)] could explain 37.43% of the differences in cumulative death rates given the cumulative incidence rates across the 58 countries (Supplementary table S1 -2, S1-3). Notably, both the classifiers used clade G percent as the most predictive attribute in the first iteration. 

The Indian subcontinent was found to have lower morality rates given the disease incidence rates (0.028, Supplementary table S4) and the clade-G viruses formed 25.96% of the proportion of viruses that had been sequenced till 11 th of June 2020. However, the clade-G virus associated with higher death rates were found to increase in frequency from 17.46% in March to 31.92% in May which formed the basis of the country-average ( Figure 2) .

Hence, to further understand the evolutionary trajectories of these viruses, 662 Indian genome sequences and the ancestral Wuhan-Hu-1 isolate sequence (NC_045512.2) were separately aligned and a total of 887 single nucleotide variants, 21 di-nucleotide, tri-nucleotide and tetra-J o u r n a l P r e -p r o o f nucleotide substitutions and 14 insertions and deletions were identified ranging in frequencies between 0.2% to >57%. A total of 545 of these variants resulted in amino acid changes ( Figure   3A , supplementary table S5). Among the single nucleotide variants C-U transition per C residue in the genome was highest at 6.15%, followed by G-U transversion (2.98%) ( Figure 3B, supplementary table S6). The NSP3 and S ORFs had the highest proportion of non-synonymous changes (NSP3: n= 106, 19.45%; S: n=80, 14.68%) ( Figure 3C supplementary table S7) . Given the number of variants identified, the diversities across all the ORFs were calculated. ORF10 was found to have the lowest nucleotide diversity (π) while ORF N had the highest. Overall, the nucleotide diversity (π) values were low across ORFs in comparison to the θ (Watterson's estimator) values ( Figure 3D ) which was indicative of the presence of higher proportion of low frequency variants as has been described in Figure 3A . The next objective was to determine if the patterns of diversity could be attributed to genetic drift or neutrality. Tajima's test for neutrality was applied and all the ORFs were found to have negative Tajima's D values ( Figure   3D ) indicative of non-neutral evolution.

To trace the ancestries of the Indian viral isolates, network analysis was carried out using the Hamming distances of variants present at ≥1% frequency among the genomes (Supplementary table S8 

In February 2020, the clade-G and GR viruses were first reported from India among Italian tourists and a contact of an Indian national with travel history to Italy. This was followed by the identification of a clade-GH virus in an individual from Delhi in mid-February 2020 ( Figure 5 ).

All the Indian clade-G viruses were found to harbor the U14,408 (RdRp: L323) variant. In states with the highest number of deaths given the number of confirmed cases like Madhya Pradesh 

In this report, for the first time our results highlight that both high age and SARS-CoV-2 clade-G viral infections can explain 37.43% of the observed variability in cumulative mortality rates across 58 countries. Further, a machine learning algorithm trained on some of these broad attributes including percent of clade-G infections has reasonably good (>70%) accuracy to classify countries into high/low mortality groups. The clade-G viruses were first reported from the Zhejiang and the Sichuan provinces in China (EPI_ISL_422425, EPI_ISL_451345) with a collection date of 1/24/2020 followed by its spread to Bavaria, Germany by way of a Chinese citizen visiting the city for work at the end of January 2020 and in line with our findings a recent report on a few European countries with high death rates have also highlighted the presence of clade-G viruses (Eaaswarkhanth et al., 2020) . Similarly, an earlier report on clinical outcome from Sheffield, England have also demonstrated the G614 mutation to be associated with higher viral loads (Korber and DC, 2020) .

In vitro studies have highlighted that incorporation of this variant stabilizes the S protein leading to greater incorporation in virus-like particles which has been speculated to have contributed to the transmission efficiency of this haplotype . Further, given that the hACE2 gene is interferon inducible in the airway epithelium (Chua et al., 2020) and infection results in increase in ACE2 production, a virus with higher proportions of S protein could mount higher inflammatory response associated with poor prognosis. However, this variant might not be contributing alone. Earlier reports on antivirals used in treatment which target the RdRp protein such as Remdesivir, Filibuvir etc. have shown these antivirals binding to the RdRp-NSP7-NSP8 complex through a hydrophobic groove involving amino acid residues F324, F325, F326 of the RdRp protein which is just next to the P323L variant site with potential to alter response to treatment with these antivirals which is in strong LD with the A23,403G (S:D614G) variant (Pachetti et al., 2020; Ruan, 2020) .

Given the pattern of virulence observed across the world, an attempt was also made to decipher the pattern of evolution among the Indian isolates to infer the ancestries of the viral isolates and build SARS-CoV-2 infection paths as has been done before (Forster, 2020) with special emphasis on the clade-G viruses . While comparing the 662 Indian SARS-CoV-2 genomes, a number of nucleotide variants or segregating sites were identified, however, the nucleotide diversity values (π) were indicative of an excess of low frequency variants. This could be because of recent population expansions as has been observed in H1N1 populations involved in outbreaks and epidemics (Martinez-Hernandez, 2010) protein-protein interactions with NSP7, NSP8 and NSP14 resulting in altered proofreading and processivity as has been speculated in earlier reports (Chand, 2020; Pachetti et al., 2020) .

These implications about the clade-G viruses need to be further tested using comprehensive clinical data and genomic data from all the countries, however, information on the presence of viral variants might prove to be useful in diagnostics and in decision making during treatment. This idea is reinforced with the recent emergence and rapid spread of the B.1.1.7 variant with multiple additional spike protein mutations [deletion 69-70 (diagnostic failure), deletion145, N501Y (increased hACE2 binding affinity), A570D, P681H (Furin cleavage site), T716I, S982A, D1118H) on the background of the G614 mutation (Kupferschmidt, 2020) .

The authors acknowledge the submitters of coronavirus sequence data to the GISAID database, the database managers, developers and scientists associated with GISAID. 

None declared. 

Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide

Median-joining networks for inferring intraspecific phylogenies

Phylogenetic clustering of the Indian SARS-CoV-2 genomes reveals the presence of distinct 1clades of viral haplotypes among states

COVID-19 severity correlates with airway epitheliumimmune cell interactions identified by single-cell analysis

Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?

Phylogenetic network analysis of SARS-CoV-2 genomes

The Numerical Results of Diverse Systems of Breeding, with Respect to Two Pairs of Characters, Linked or Independent, with Special Relation to the Effects of Linkage

Potential association between COVID-19 mortality and health-care resource availability. The Lancet

Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2

MEGA X: Molecular Evolutionary Genetics Analysis across computing platforms

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

What happened after the initial global spread of pandemic human influenza virus A (H1N1)? A population genetics approach

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

Potential Inhibitors Targeting RNA-Dependent RNA Polymerase Activity (NSP12) of SARS-CoV-2

Statistical methods to test for nucleotide mutation hypothesis by DNA polymorphism

A new coronavirus associated with human respiratory disease in China

Viral and host factors related to the clinical outcome of COVID-19

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Experiments with a New Boosting Algorithm

Additive logistic regression: a statistical view of boosting (With discussion and a rejoinder by the authors)

Mutant coronavirus in the United Kingdom sets off alarms, but its importance remains unclear